Enantioselective, mechanism-based inactivation of guinea pig hepatic cytochrome P450 by N-(α-methylbenzyl)-1-aminobenzotriazole

Drug Metabolism and Disposition

Volumn 26, Issue 7, 1998, Pages 681-688

  Sinal, Christopher J ^b   Hirst, Maurice ^b   Webb, Christopher D ^b   Bend, John R ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINOBENZOTRIAZOLE; CYTOCHROME P450; ETHOXYRESORUFIN DEETHYLASE; N (ALPHA METHYLBENZYL) 1 AMINOBENZOTRIAZOLE; PENTOBARBITAL; PENTOXYRESORUFIN DEALKYLASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENANTIOMER; ENZYME ACTIVITY; ENZYME INACTIVATION; GUINEA PIG; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; STEREOCHEMISTRY;

ANIMALS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2B1; GUINEA PIGS; HALF-LIFE; ISOENZYMES; MICROSOMES, LIVER; STEREOISOMERISM; TRIAZOLES;

EID: 0031814680     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Beckett AH and Gibson GG (1978) Stereochemistry of the metabolic incorporation of oxygen into (+)- and (-)N-benzylamphetamine. Xenobiotica 8:73-83.
2. Bend JR, Hook GER, Easterling RE, Gram TE and Fouts JR (1972) A comparative study of the hepatic and pulmonary mixed-function oxidate systems in the rabbit. J Pharmacol Exp Ther 183:206-217.
3. Bend JR, Serabjit-Singh CJ and Philpot RM (1985) The pulmonary uptake, accumulation, and metabolism of xenobiotics. Annu Rev Pharmacol Toxicol 25:97-125.
4. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T and Mayer RT (1985) Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P450. Biochem Pharmacol 34:3337-3345.
5. Estabrook RW, Peterson J, Baron J and Hildebrandt A (1972) The spectrophotometric measurement of turbid suspensions of cytochromes associated with drug metabolism, in Methods of Pharmacology, vol. 2 (Chignell CF ed) pp 303-350, Appleton-Century-Crofts, New York.
6. Gasyna Z, Browett WR, Nyokong T, Kitchenham B and Stillman MJ (1989) Interactive computing for instrument control and data analysis in photochemical studies. Chemometrics Intelligent Lab Syst 5:233-246.
7. Gonzalez FJ, Liu S-Y and Yano M (1993) Regulation of cytochrome P450 genes: molecular mechanisms. Pharmacogenetics 3:51-57.
8. Grimm SW, Bend JR and Halpert JR (1995) Selectivity and kinetics of inactivation of rabbit hepatic cytochromes P450 2B4 and 2B5 by N-aralkylated derivatives of 1-aminobenzotriazole. Drug Metab Dispos 23:577-583.
9. Halpert JR (1995) Structural basis of selective cytochrome P450 inhibition. Annu Rev Pharmacol Toxicol 35:29-53.
10. Halpert JR, Guengerich FP, Bend JR and Correia MA (1994) Selective inhibitors of cytochromes P450. Toxicol Appl Pharmacol 125:163-175.
11. Johnson WC, Fontana LP and Smith HE (1987) Far ultraviolet circular dichroism observations on the substituted benzene chromophore. J Am Chem Soc 109:3361-3366.
12. Kent UE, Bend JR, Chamberlin BA, Gage DA and Hollenberg PF (1997a) Mechanism-based inactivation of cytochrome P450 2B1 by N-benzyl-1-aminobenzotriazole. Chem Res Toxicol 10:600-608.
13. Kent UE, Hanna IH, Szklarz GD, Vaz ADN, Halpert JR, Bend JR and Hollenberg PF (1997b) Significance of glycine 478 in the metabolism of N-benzyl-1-aminobenzotriazole to reactive intermediates by cytochrome P450 2B1. Biochemistry 36:11707-11716.
14. Kitz R and Wilson IB (1962) Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. J Biol Chem 237:3245-3250.
15. Knickle LC and Bend JR (1992) Dose-dependent, mechanism-based inactivation of cytochrome P450 monooxygenases in vivo by 1-aminobenzotriazole in liver, lung and kidney of untreated, phenobarbital-treated and β-naphthoflavone-treated guinea pigs. Can J Physiol Pharmacol 70:1610-1617.
16. Knickle LC and Bend JR (1994) Bioactivalion of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for the formation of epoxyeicosatrienoic acids. Mol Pharmacol 45:1273-1280.
17. Knickle LC, Philpot RM and Bend JR (1994) N-Aralkylated derivatives of 1-aminobenzotriazole are potent isozyme- and lung-selective mechanism-based inhibitors of guinea pig cytochrome P450 in vivo. J Pharmacol Exp Ther 270:377-385.
18. Knickle LC, Webb CD, House AA and Bend JR (1993) Mechanism-based inactivation of cytochrome P450 1A1 by N-aralkyl-1-aminobenzotriazoles in guinea pig kidney in vivo and in vitro: minimal effects on metabolism of arachidonic acid by renal P450-dependent monooxygenases. J Pharmacol Exp Ther 267:758-764
19. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
20. Lubet RA, Mayer RT, Cameron JW, Nims RW, Burke MD, Wolff T and Guengerich FP (1985) Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P450 by phenobarbital and other xenobiotics in the rat. Arch Biochem Biophys 238:43-48.
21. Mathews JM and Bend JR (1986) N-Alkylaminobenzotriazoles as isozyme-selective suicide inhibitors of rabbit pulmonary microsomal cytochrome P450. Mol. Pharmacol 30:25-32.
22. Mathews JM and Bend JR (1993) N-Aralkyl derivatives of 1-aminobenzotriazole as potent isozyme-selective mechanism-based inhibitors of rabbit pulmonary cytochrome P450 in vivo. J Pharmacol Exp Ther 265:281-285.
23. Nelson DR Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC and Nebert DW (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature Pharmacogenetics 6:1-42.
24. Nerurkar PV, Park SS, Thomas PE, Nims RW and Lubet RA (1993) Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochem Pharmacol 46:933-943.
25. Park BK, Pirmohamed M and Kitteringham NR (1995) The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity. Pharmacol Ther 68:385-424.
26. Prough RA, Linder MW, Pinaire JA, Xiao G-H and Falkner KC (1996) Hormonal regulation of hepatic enzymes involved in foreign compound metabolism. FASEB J 10:1369-1377.
27. Rando RR (1984) Mechanism-based enzyme inactivators. Pharmacol Rev 36:111-142
28. Serabjit-Singh CJ, Albro PW, Robertson IGC and Philpot RM (1983) Interactions between xenobiotics that increase or decrease the levels of cytochrome P-450 isozymes in rabbit lung and liver. J Biol Chem 258:12827-12834.
29. Sinal CJ and Bend JR (1995) Isozyme-selective metabolic intermediate complex formation of guinea pig hepatic cytochrome P450 by N-aralkylated derivatives of 1-aminobenzotriazole. Chem Res Toxicol 8:82-91.
30. Sinal CJ and Bend JR (1996) Kinetics and selectivity of mechanism-based inhibition of guinea pig hepatic and pulmonary cytochrome P450 by N-benzyl-1-aminobenzotriazole and N-α-methylbenzyl-1-aminobenzotriazole. Drug Metab Dispos 24:996-1001.
31. Smith HE, Warren MEJ and Katzin LI (1968) Optically active amines. VIII. Optical rotatory dispersion observations on α- and β-arylalkylamine. Tetrahedron 24:1327-1335.
32. Woodcraft KJ and Bend JR (1990) N-Aralkylated derivatives of 1-aminobenzotriazole as isozyme-selective, mechanism-based inhibitors of guinea pig hepatic cytochrome P450 dependent monooxygenase activity. Can J Physiol Pharmacol 68:1278-1285.
33. Woodcraft KJ, Szczepan EW, Knickle LC and Bend JR (1990) Three N-aralkylated derivatives of 1-aminobenzotriazole as potent and isozyme-selective, mechanism-based inhibitors of guinea pig pulmonary cytochrome P450 in vitro. Drug Metab Dispos 18:1031-1037.
34. Woodcraft KJ, Webb CJ, Yao M, Weedon AC and Bend JR (1997) Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole. Chem Res Toxicol 10:589-599.